Three versus 12‐month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Three versus 12‐month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta‐analysis of randomized controlled trials

Published:2022-11-03 Issue:7 Volume:100 Page:1151-1158
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Selvaraj Vijairam¹^ORCID,Chatterjee Saurav²^ORCID,Hirai Taishi³,Abbott J. Dawn⁴,Bavishi Chirag³^ORCID

Affiliation:

1. Department of Medicine, Warren Alpert Medical School of Brown University Miriam Hospital Providence Rhode Island USA

2. Division of Cardiology, Northwell Health Zucker School of Medicine New York City New York USA

3. Division of Cardiology University of Missouri School of Medicine Columbia Missouri USA

4. Division of Cardiology, Lifespan Cardiovascular Institute Warren Alpert Medical School at Brown University Providence Rhode Island USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30467

Reference34 articles.

1. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease

2. Risk Factors for Rehospitalization for Acute Coronary Syndromes and Unplanned Revascularization Following Acute Myocardial Infarction

3. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)

4. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

5. Bleeding risk, dual antiplatelet therapy cessation, and adverse events after percutaneous coronary intervention: the Paris registry;Sorrentino S;Circulation: Cardiovasc Interv,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm;Internal and Emergency Medicine;2024-04-10

2. Modern ways to reduced mortality of myocardial infarction. What should be done?;Сибирский научный медицинский журнал;2023-10-27

3. Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis;Life;2023-02-28